Blockchain Registration Transaction Record

Silo Pharma Collaborates with Veloxity Labs for Ongoing Study of PTSD Treatment SPC-15

Silo Pharma partners with Veloxity Labs for GLP-compliant bioanalysis of PTSD treatment SPC-15. Collaboration aims to advance innovative therapies for stress-induced psychiatric disorders and chronic pain. Exciting developments in the biopharmaceutical industry.

Silo Pharma Collaborates with Veloxity Labs for Ongoing Study of PTSD Treatment SPC-15

This news matters as it highlights the progress of Silo Pharma in developing innovative treatments for stress-induced psychiatric disorders and chronic pain conditions. The partnership with Veloxity Labs signifies a significant step towards potentially addressing PTSD with the intranasal treatment SPC-15, offering hope for individuals suffering from these conditions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xa8f77beb4503f14ac63dbc9b6b19e6df70763b67f61ba2fb8b55f3b8b7949ced
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintenvy3Upz-eee9609d93465c50d23fa08426915ad0